Back to Search Start Over

The warfarin–cranberry juice interaction revisited: A systematic in vitro–in vivo evaluation

Authors :
Ngo,Ngoc
Brantley,Scott
Carrizosa,Daniel
Kashuba,Angela
Dees,Claire
Kroll,David J.
Oberlies,Nicholas
Paine,Mary
Ngo,Ngoc
Brantley,Scott
Carrizosa,Daniel
Kashuba,Angela
Dees,Claire
Kroll,David J.
Oberlies,Nicholas
Paine,Mary
Publication Year :
2010

Abstract

Ngoc Ngo1, Scott J Brantley1, Daniel R Carrizosa2, Angela DM Kashuba1, E Claire Dees2, David J Kroll3, Nicholas H Oberlies4, Mary F Paine11UNC Eshelman School of Pharmacy and 2Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 3Biomanufacturing Research Institute and Technology Enterprise and the Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC, USA; 4Department of Chemistry and Biochemistry, The University of North Carolina at Greensboro, Greensboro, NC, USABackground: Cranberry products have been implicated in several case reports to enhance the anticoagulant effect of warfarin. The mechanism could involve inhibition of the hepatic CYP2C9-mediated metabolic clearance of warfarin by components in cranberry. Because dietary/natural substances vary substantially in bioactive ingredient composition, multiple cranberry products were evaluated in vitro before testing this hypothesis in vivo.Methods: The inhibitory effects of five types of cranberry juices were compared with those of water on CYP2C9 activity (S-warfarin 7-hydroxylation) in human liver microsomes (HLM). The most potent juice was compared with water on S/R-warfarin pharmacokinetics in 16 healthy participants given a single dose of warfarin 10 mg.Results: Only one juice inhibited S-warfarin 7-hydroxylation in HLM in a concentration-dependent manner (P < 0.05), from 20% to >95% at 0.05% to 0.5% juice (v/v), respectively. However, this juice had no effect on the geometric mean AUC00-oo and terminal half-life of S/R-warfarin in human subjects.Conclusions: A cranberry juice that inhibited warfarin metabolism in HLM had no effect on warfarin clearance in healthy participants. The lack of an in vitro–in vivo concordance likely reflects the fact that the site of warfarin metabolism (liver) is remote from the site of exposure to the inhibitory components in the cranberry juice (intestine).Keywords: warfarin, cran

Details

Database :
OAIster
Notes :
text/html, English
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn747671504
Document Type :
Electronic Resource